MTAP gene deletion in endometrial cancer

Gynecologic and Obstetric Investigation

Volumn 45, Issue 4, 1998, Pages 272-276

  Wong, Y F ^a   Chung, T K H ^a   Cheung, T H ^a   Nobori, T ^b   Chang, A M Z ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Deletion; Endometrial cancer; MTAP

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; 5' METHYLTHIORIBOSE 1 PHOSPHATE; ADENINE; ADENINE NUCLEOTIDE; METHIONINE; POLYAMINE; PUTRESCINE; S ADENOSYLMETHIONINE; SPERMIDINE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 9P; CLINICAL ARTICLE; DRUG SENSITIVITY; ENDOMETRIUM CANCER; ENZYME INHIBITION; ENZYME SUBSTRATE; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 9; ENDOMETRIAL NEOPLASMS; FEMALE; GENE DELETION; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PURINE-NUCLEOSIDE PHOSPHORYLASE;

EID: 0031745606     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000009983     Document Type: Article

References (14)

1. Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL, Carson DA: Genomic cloning of methylthioadenosine phosphorylase: A purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci USA 1996;93:6203-6208.
2. Savarese TM, Dexter DL, Parks RE Jr: 5′-Deoxy-5′-methylthioadenosine phosphorylase. II. Role of the enzyme in the metabolism and antineoplastic action of adenine-substituted analogs of 5′-deoxy-5′-methylthioadenosine. Biochem Pharmacol 1983;32:1907-1916.
3. Nobori T, Karras JG, Della Ragione F, Waltz TA, Chen PP, Carson DA: Absence of methylthioadenosine phosphorlyase in human gliomas. Cancer Res 1991;51:3193-3197.
4. Nobori T, Szinai I, Amox D, Parker B, Olopade OI, Buchhagen DL, Carson DA: Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res 1993; 53:1098-1101.
5. Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade OI: Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 1994;54:2060-2063.
6. Jagasia AA, Block JA, Qureshi A, Diaz MO, Nobori T, Gitelis S, Iyer AP: Chromosome 9 related aberrations and deletion of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas. Cancer Lett 1996; 105:91-103.
7. Della Ragione F, Oliva A, Palumbo R, Russo GL, Gragnaniello V, Zappia V: Deficiency of 5′-deoxy-5′-methylthioadenosine phosphorylase activity in malignancy: Absence of the protein in human enzyme-deficient cell lines. Biochem J 1992;281:533-538.
8. Wu DJ, Reynolds L, Carson DA, Nobori T: Molecular, genetic analysis of chromosome 9p in methylthioadenosine phosphorylase deficient glioma cell lines. Adv Exp Med Biol 1991; 309B:207-211.
9. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
10. INK4B alterations in primary gynecologic malignancy. Gynecol Oncol 1997;65:319-324.
11. Tran PT, Hori H, Okumura K, Kagotani K, Taguchi H, Carson DA, Nobori T: Molecular cloning of the human methylthioadenosine phosphorylase processed pseudogene and localization to 3q28. Gene 1997;186:263-269.
12. INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines. Cancer Genet Cytogenet 1996;86:22-28.
13. INK4, methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Cancer Res 1996;56:1083-1090.
14. Hori H, Tran P, Carrera CJ, Hori Y, Rosenbach MD, Carson DA, Nobori T: Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells. Cancer Res 1996;56:5653-5658.